BioClinica Expands Osteoarthritis Trial Imaging Support

Loading...
Loading...
BioClinica
BIOC
today announced the immediate availability of new and expanded imaging services critical for clinical trials in the area of osteoarthritis (OA), a disease affecting over 21 million people in the United States. Colin G. Miller PhD FICR CSci, Senior Vice President of Medical Affairs, commented “BioClinica has been actively involved in the OA Imaging field for both Disease Modifying Osteoarthritis Drugs (DMOADs) and cartilage repair for years. We have amassed a thorough understanding of the FDA requirements and the challenges for these clinical trials. A new proprietary BioClinica positioning device was specifically developed to provide highly reproducible radiographs of subjects' knees and
See full press release
Posted In: EarningsNewsGuidanceManagementGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...